Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Accumulated Expenses of $6.64 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 21.1% from $8.42 million a year earlier and down 28.1% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Accumulated Expenses of $8.76 million, down 0.6% from FY2025.

  • Accumulated Expenses has a five-year compound annual growth rate of 41.1% (FY2021 to FY2026).
  • By fiscal year, Accumulated Expenses came in at $8.81 million in FY2025 (+294.2%), $2.24 million in FY2024 (+180.8%), $796,000 in FY2023 (-40.1%) and $1.33 million in FY2022 (-14.9%).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Accumulated Expenses since fiscal Q1 2026.
  • Year over year, Accumulated Expenses gained in five of the last seven quarters, with growth averaging 101.0%.
  • The high point for year-over-year Accumulated Expenses in five years was fiscal Q3 2022 (growth of 418.0%); the low point was fiscal Q3 2024 (a decline of 88.1%).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $9.24 million (Q1 2027), $8.76 million (Q4 2026) and $9.25 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.64 Mn
Jun 30, 2026 9.24 Mn
Mar 31, 2026 8.76 Mn
Dec 31, 2025 9.25 Mn
Sep 30, 2025 8.42 Mn
Jun 30, 2025 6.58 Mn
Mar 31, 2025 8.81 Mn
Dec 31, 2024 5.47 Mn
Sep 30, 2024 3.82 Mn
Jun 30, 2024 2.16 Mn
Mar 31, 2024 2.24 Mn
Dec 31, 2023 129,300.00
Sep 30, 2023 292,600.00
Jun 30, 2023 424,700.00
Mar 31, 2023 796,000.00
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 727,300.00
Mar 31, 2022 1.33 Mn
Dec 31, 2021 2.63 Mn
API Access

Vistagen Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY